Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Comment by TheGamerson Nov 28, 2017 9:31pm
69 Views
Post# 27050986

RE:RE:RE:RE:RE:RE:Financials

RE:RE:RE:RE:RE:RE:Financials2016 Q1 dropped Dec. 30, with the fact the year end finaiclas dropped the same day we could probably expect them on Dec. 30th as well. Which will be a good read to see exactly what 10x the expected revenue means as we seem to have $362k biological and $180K other assets.

Droid or anyone who can respond other then DYODD, reading the capital commitments Alumina is straight forward to how the warrants and prices are calculated. If there was a spot for clarification as to why John is recieving 25% warrants each time, I expected it to be required to be outlined here. 

Have you or anyone come across another situation where a person would recieve warrants as such but not have it outlined in the commitments or explained. I have been unable to locate even a similar situation.
Bullboard Posts